[HTML][HTML] Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast …
HJ Burstein, G Curigliano, B Thürlimann, WP Weber… - Annals of oncology, 2021 - Elsevier
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose …
I Meattini, C Becherini, L Boersma… - The Lancet …, 2022 - thelancet.com
High-quality randomised clinical trials testing moderately fractionated breast radiotherapy
have clearly shown that local control and survival is at least as effective as with 2 Gy daily …
have clearly shown that local control and survival is at least as effective as with 2 Gy daily …
Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology
WJ Gradishar, MS Moran, J Abraham, R Aft… - Journal of the National …, 2022 - jnccn.org
The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open …
BH Chua, EK Link, IH Kunkler, TJ Whelan… - The Lancet, 2022 - thelancet.com
Background Whole breast irradiation (WBI) after conservative surgery for ductal carcinoma
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …
in situ (DCIS) reduces local recurrence. We investigated whether a tumour bed boost after …
Partial breast irradiation versus whole breast irradiation for early breast cancer patients in a randomized phase III trial: the Danish breast cancer group partial breast …
BV Offersen, J Alsner, HM Nielsen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE On the basis of low risk of local recurrence in elderly patients with breast cancer
after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast …
after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast …
Tumor response to radiopharmaceutical therapies: the knowns and the unknowns
Radiopharmaceutical therapy (RPT) is defined as the delivery of radioactive atoms to tumor-
associated targets. In RPT, imaging is built into the mode of treatment since the …
associated targets. In RPT, imaging is built into the mode of treatment since the …
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy
after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST …
after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST …
Harnessing progress in radiotherapy for global cancer control
The pace of technological innovation over the past three decades has transformed the field
of radiotherapy into one of the most technologically intense disciplines in medicine …
of radiotherapy into one of the most technologically intense disciplines in medicine …
[HTML][HTML] Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer …
M Overgaard, HM Nielsen, T Tramm, I Højris… - Radiotherapy and …, 2022 - Elsevier
Abstract Background Between 1982 and 1990 the Danish Breast Cancer Cooperative Group
(DBCG) conducted a randomized trial in high-risk pre-and postmenopausal (< 70 years) …
(DBCG) conducted a randomized trial in high-risk pre-and postmenopausal (< 70 years) …
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
HM Dahn, LJ Boersma, D De Ruysscher… - Critical Reviews in …, 2021 - Elsevier
Purpose Post mastectomy radiation therapy (PMRT) reduces locoregional recurrence (LRR)
and breast cancer mortality for selected patients. Bolus overcomes the skin-sparing effect of …
and breast cancer mortality for selected patients. Bolus overcomes the skin-sparing effect of …